Aptus takes $30M to repair aneurysms
Aptus Endosystems, a biotech firm working on a device to fix abdominal aneurysms, just brought in $30 million in third-round funding to finish off clinical trials of its Abdominal Aortic Aneurysm Repair System, reports VentureWire. Heron Capital led the round, which also included Longitude Capital,… Continue Reading
Baird Venture Partners gets a new $170M fund
Baird Venture Partners, which is a life science and information tech investor has closed its third fund. At $170 million it’s over twice as large as its previous one, according to VentureWire.
This new fund is expected to dish out money to about 20 companies. Given… Continue Reading
Life-science briefing: Thursday, April 3, 2008
TODAY’S HEADLINES:
Mirna Thera spins out of Asuragen with $3M (release)
Stroke-therapy startup CoAxia raises $12M (release)
Stealthy device maker Synvascular gets $6.5M (peHUB)
AndroScience seeks $3.5M for anti-testosterone drugs (VentureWire)
Austria’s ProtAffin takes in €1.1M grant (release)
Singapore’s Moleac receives $3.5M for Chinese medicine (release)
Alethia Bio gets C$2.4M for antibody… Continue Reading